XML 89 R61.htm IDEA: XBRL DOCUMENT
v3.25.2

SHARE CAPITAL - Summary of stock option information (Details) $ / shares in Units, $ in Thousands | 12 Months Ended |  |  |  |  |  |  |  |  |
--- | --- | --- | --- | --- | --- | --- | --- | --- | --- | ---
Mar. 31, 2025 shares | Mar. 31, 2025 CAD ($) | Mar. 31, 2025 option | Mar. 31, 2025 $ / shares | Mar. 07, 2025 CAD ($) | Nov. 27, 2024 CAD ($) | Aug. 15, 2024 CAD ($) | Apr. 05, 2024 CAD ($) | Mar. 31, 2024 shares | Mar. 20, 2024 CAD ($) | Jun. 29, 2023 CAD ($) | Mar. 31, 2023 shares
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items] |  |  |  |  |  |  |  |  |  |  |  |
Number of share options outstanding (in shares) | 3,956,684 |  | 3,956,684 |  |  |  |  |  | 1,742,139 |  |  | 778,163
Number of options exercisable (in shares) | 3,591,976 |  | 3,591,976 |  |  |  |  |  |  |  |  |
Estimated grant date fair value | $ |  | $ 47,427 |  |  |  |  |  |  |  |  |  |
Weighted average remaining life | 8 years 1 month 17 days |  |  |  |  |  |  |  |  |  |  |
Option Expiration Period One |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items] |  |  |  |  |  |  |  |  |  |  |  |
Number of share options outstanding (in shares) |  |  | 986 |  |  |  |  |  |  |  |  |
Number of options exercisable (in shares) |  |  | 986 |  |  |  |  |  |  |  |  |
Exercise price (in dollars per share) | $ / shares |  |  |  | $ 13.11 |  |  |  |  |  |  |  |
Estimated grant date fair value | $ |  | 11 |  |  |  |  |  |  |  |  |  |
Weighted average remaining life | 7 days |  |  |  |  |  |  |  |  |  |  |
Option Expiration Period Two |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items] |  |  |  |  |  |  |  |  |  |  |  |
Number of share options outstanding (in shares) |  |  | 2,372 |  |  |  |  |  |  |  |  |
Number of options exercisable (in shares) |  |  | 2,372 |  |  |  |  |  |  |  |  |
Exercise price (in dollars per share) | $ / shares |  |  |  | 16.72 |  |  |  |  |  |  |  |
Estimated grant date fair value | $ |  | 32 |  |  |  |  |  |  |  |  |  |
Weighted average remaining life | 7 days |  |  |  |  |  |  |  |  |  |  |
Option Expiration Period Three |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items] |  |  |  |  |  |  |  |  |  |  |  |
Number of share options outstanding (in shares) |  |  | 986 |  |  |  |  |  |  |  |  |
Number of options exercisable (in shares) |  |  | 986 |  |  |  |  |  |  |  |  |
Exercise price (in dollars per share) | $ / shares |  |  |  | 21.28 |  |  |  |  |  |  |  |
Estimated grant date fair value | $ |  | 15 |  |  |  |  |  |  |  |  |  |
Weighted average remaining life | 7 days |  |  |  |  |  |  |  |  |  |  |
Option Expiration Period Four |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items] |  |  |  |  |  |  |  |  |  |  |  |
Number of share options outstanding (in shares) |  |  | 1,161 |  |  |  |  |  |  |  |  |
Number of options exercisable (in shares) |  |  | 1,161 |  |  |  |  |  |  |  |  |
Exercise price (in dollars per share) | $ / shares |  |  |  | 66.12 |  |  |  |  |  |  |  |
Estimated grant date fair value | $ |  | 55 |  |  |  |  |  |  |  |  |  |
Weighted average remaining life | 7 days |  |  |  |  |  |  |  |  |  |  |
Option Expiration Period Five |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items] |  |  |  |  |  |  |  |  |  |  |  |
Number of share options outstanding (in shares) |  |  | 27,631 |  |  |  |  |  |  |  |  |
Number of options exercisable (in shares) |  |  | 27,631 |  |  |  |  |  |  |  |  |
Exercise price (in dollars per share) | $ / shares |  |  |  | 9.50 |  |  |  |  |  |  |  |
Estimated grant date fair value | $ |  | 188 |  |  |  |  |  |  |  |  |  |
Weighted average remaining life | 2 months 15 days |  |  |  |  |  |  |  |  |  |  |
Option Expiration Period Six |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items] |  |  |  |  |  |  |  |  |  |  |  |
Number of share options outstanding (in shares) |  |  | 5,263 |  |  |  |  |  |  |  |  |
Number of options exercisable (in shares) |  |  | 5,263 |  |  |  |  |  |  |  |  |
Exercise price (in dollars per share) | $ / shares |  |  |  | 34.20 |  |  |  |  |  |  |  |
Estimated grant date fair value | $ |  | 73 |  |  |  |  |  |  |  |  |  |
Weighted average remaining life | 3 months |  |  |  |  |  |  |  |  |  |  |
Option Expiration Period Seven |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items] |  |  |  |  |  |  |  |  |  |  |  |
Number of share options outstanding (in shares) |  |  | 7,106 |  |  |  |  |  |  |  |  |
Number of options exercisable (in shares) |  |  | 7,106 |  |  |  |  |  |  |  |  |
Exercise price (in dollars per share) | $ / shares |  |  |  | 28.50 |  |  |  |  |  |  |  |
Estimated grant date fair value | $ |  | 97 |  |  |  |  |  |  |  |  |  |
Weighted average remaining life | 6 months |  |  |  |  |  |  |  |  |  |  |
Option Expiration Period Eight |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items] |  |  |  |  |  |  |  |  |  |  |  |
Number of share options outstanding (in shares) |  |  | 25,000 |  |  |  |  |  |  |  |  |
Number of options exercisable (in shares) |  |  | 25,000 |  |  |  |  |  |  |  |  |
Exercise price (in dollars per share) | $ / shares |  |  |  | 28.50 |  |  |  |  |  |  |  |
Estimated grant date fair value | $ |  | 509 |  |  |  |  |  |  |  |  |  |
Weighted average remaining life | 7 months 6 days |  |  |  |  |  |  |  |  |  |  |
Option Expiration Period Nine |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items] |  |  |  |  |  |  |  |  |  |  |  |
Number of share options outstanding (in shares) |  |  | 9,869 |  |  |  |  |  |  |  |  |
Number of options exercisable (in shares) |  |  | 9,869 |  |  |  |  |  |  |  |  |
Exercise price (in dollars per share) | $ / shares |  |  |  | 28.50 |  |  |  |  |  |  |  |
Estimated grant date fair value | $ |  | 110 |  |  |  |  |  |  |  |  |  |
Weighted average remaining life | 7 months 17 days |  |  |  |  |  |  |  |  |  |  |
Option Expiration Period Ten |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items] |  |  |  |  |  |  |  |  |  |  |  |
Number of share options outstanding (in shares) |  |  | 5,263 |  |  |  |  |  |  |  |  |
Number of options exercisable (in shares) |  |  | 5,263 |  |  |  |  |  |  |  |  |
Exercise price (in dollars per share) | $ / shares |  |  |  | 34.58 |  |  |  |  |  |  |  |
Estimated grant date fair value | $ |  | 53 |  |  |  |  |  |  |  |  |  |
Weighted average remaining life | 7 months 17 days |  |  |  |  |  |  |  |  |  |  |
Option Expiration Period Eleven |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items] |  |  |  |  |  |  |  |  |  |  |  |
Number of share options outstanding (in shares) |  |  | 5,263 |  |  |  |  |  |  |  |  |
Number of options exercisable (in shares) |  |  | 5,263 |  |  |  |  |  |  |  |  |
Exercise price (in dollars per share) | $ / shares |  |  |  | 56.24 |  |  |  |  |  |  |  |
Estimated grant date fair value | $ |  | 211 |  |  |  |  |  |  |  |  |  |
Weighted average remaining life | 8 months 12 days |  |  |  |  |  |  |  |  |  |  |
Option Expiration Period Twelve |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items] |  |  |  |  |  |  |  |  |  |  |  |
Number of share options outstanding (in shares) |  |  | 2,829 |  |  |  |  |  |  |  |  |
Number of options exercisable (in shares) |  |  | 2,829 |  |  |  |  |  |  |  |  |
Exercise price (in dollars per share) | $ / shares |  |  |  | 66.12 |  |  |  |  |  |  |  |
Estimated grant date fair value | $ |  | 131 |  |  |  |  |  |  |  |  |  |
Weighted average remaining life | 8 months 15 days |  |  |  |  |  |  |  |  |  |  |
Option Expiration Period Thirteen |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items] |  |  |  |  |  |  |  |  |  |  |  |
Number of share options outstanding (in shares) |  |  | 2,500 |  |  |  |  |  |  |  |  |
Number of options exercisable (in shares) |  |  | 2,500 |  |  |  |  |  |  |  |  |
Exercise price (in dollars per share) | $ / shares |  |  |  | 13.11 |  |  |  |  |  |  |  |
Estimated grant date fair value | $ |  | 28 |  |  |  |  |  |  |  |  |  |
Weighted average remaining life | 9 months |  |  |  |  |  |  |  |  |  |  |
Option Expiration Period Fourteen |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items] |  |  |  |  |  |  |  |  |  |  |  |
Number of share options outstanding (in shares) |  |  | 3,947 |  |  |  |  |  |  |  |  |
Number of options exercisable (in shares) |  |  | 3,947 |  |  |  |  |  |  |  |  |
Exercise price (in dollars per share) | $ / shares |  |  |  | 16.72 |  |  |  |  |  |  |  |
Estimated grant date fair value | $ |  | 53 |  |  |  |  |  |  |  |  |  |
Weighted average remaining life | 9 months |  |  |  |  |  |  |  |  |  |  |
Option Expiration Period Fifteen |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items] |  |  |  |  |  |  |  |  |  |  |  |
Number of share options outstanding (in shares) |  |  | 5,263 |  |  |  |  |  |  |  |  |
Number of options exercisable (in shares) |  |  | 5,263 |  |  |  |  |  |  |  |  |
Exercise price (in dollars per share) | $ / shares |  |  |  | 21.28 |  |  |  |  |  |  |  |
Estimated grant date fair value | $ |  | 79 |  |  |  |  |  |  |  |  |  |
Weighted average remaining life | 9 months |  |  |  |  |  |  |  |  |  |  |
Option Expiration Period Sixteen |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items] |  |  |  |  |  |  |  |  |  |  |  |
Number of share options outstanding (in shares) |  |  | 1,974 |  |  |  |  |  |  |  |  |
Number of options exercisable (in shares) |  |  | 1,974 |  |  |  |  |  |  |  |  |
Exercise price (in dollars per share) | $ / shares |  |  |  | 77.14 |  |  |  |  |  |  |  |
Estimated grant date fair value | $ |  | 109 |  |  |  |  |  |  |  |  |  |
Weighted average remaining life | 10 months 17 days |  |  |  |  |  |  |  |  |  |  |
Option Expiration Period Seventeen |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items] |  |  |  |  |  |  |  |  |  |  |  |
Number of share options outstanding (in shares) |  |  | 5,725 |  |  |  |  |  |  |  |  |
Number of options exercisable (in shares) |  |  | 5,725 |  |  |  |  |  |  |  |  |
Exercise price (in dollars per share) | $ / shares |  |  |  | 52.82 |  |  |  |  |  |  |  |
Estimated grant date fair value | $ |  | 217 |  |  |  |  |  |  |  |  |  |
Weighted average remaining life | 11 months 8 days |  |  |  |  |  |  |  |  |  |  |
Option Expiration Period Eighteen |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items] |  |  |  |  |  |  |  |  |  |  |  |
Number of share options outstanding (in shares) |  |  | 7,895 |  |  |  |  |  |  |  |  |
Number of options exercisable (in shares) |  |  | 7,895 |  |  |  |  |  |  |  |  |
Exercise price (in dollars per share) | $ / shares |  |  |  | 58.90 |  |  |  |  |  |  |  |
Estimated grant date fair value | $ |  | 360 |  |  |  |  |  |  |  |  |  |
Weighted average remaining life | 11 months 15 days |  |  |  |  |  |  |  |  |  |  |
Option Expiration Period Nineteen |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items] |  |  |  |  |  |  |  |  |  |  |  |
Number of share options outstanding (in shares) |  |  | 987 |  |  |  |  |  |  |  |  |
Number of options exercisable (in shares) |  |  | 987 |  |  |  |  |  |  |  |  |
Exercise price (in dollars per share) | $ / shares |  |  |  | 50.16 |  |  |  |  |  |  |  |
Estimated grant date fair value | $ |  | 35 |  |  |  |  |  |  |  |  |  |
Weighted average remaining life | 11 months 26 days |  |  |  |  |  |  |  |  |  |  |
Option Expiration Period Twenty |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items] |  |  |  |  |  |  |  |  |  |  |  |
Number of share options outstanding (in shares) |  |  | 4,342 |  |  |  |  |  |  |  |  |
Number of options exercisable (in shares) |  |  | 4,342 |  |  |  |  |  |  |  |  |
Exercise price (in dollars per share) | $ / shares |  |  |  | 13.11 |  |  |  |  |  |  |  |
Estimated grant date fair value | $ |  | 49 |  |  |  |  |  |  |  |  |  |
Weighted average remaining life | 1 year |  |  |  |  |  |  |  |  |  |  |
Option Expiration Period Twenty One |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items] |  |  |  |  |  |  |  |  |  |  |  |
Number of share options outstanding (in shares) |  |  | 3,339 |  |  |  |  |  |  |  |  |
Number of options exercisable (in shares) |  |  | 3,339 |  |  |  |  |  |  |  |  |
Exercise price (in dollars per share) | $ / shares |  |  |  | 16.72 |  |  |  |  |  |  |  |
Estimated grant date fair value | $ |  | 44 |  |  |  |  |  |  |  |  |  |
Weighted average remaining life | 1 year |  |  |  |  |  |  |  |  |  |  |
Option Expiration Period Twenty Two |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items] |  |  |  |  |  |  |  |  |  |  |  |
Number of share options outstanding (in shares) |  |  | 986 |  |  |  |  |  |  |  |  |
Number of options exercisable (in shares) |  |  | 986 |  |  |  |  |  |  |  |  |
Exercise price (in dollars per share) | $ / shares |  |  |  | 21.28 |  |  |  |  |  |  |  |
Estimated grant date fair value | $ |  | 15 |  |  |  |  |  |  |  |  |  |
Weighted average remaining life | 1 year |  |  |  |  |  |  |  |  |  |  |
Option Expiration Period Twenty Three |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items] |  |  |  |  |  |  |  |  |  |  |  |
Number of share options outstanding (in shares) |  |  | 4,475 |  |  |  |  |  |  |  |  |
Number of options exercisable (in shares) |  |  | 4,475 |  |  |  |  |  |  |  |  |
Exercise price (in dollars per share) | $ / shares |  |  |  | 110.20 |  |  |  |  |  |  |  |
Estimated grant date fair value | $ |  | 355 |  |  |  |  |  |  |  |  |  |
Weighted average remaining life | 1 year 2 months 26 days |  |  |  |  |  |  |  |  |  |  |
Option Expiration Period Twenty Four |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items] |  |  |  |  |  |  |  |  |  |  |  |
Number of share options outstanding (in shares) |  |  | 25,657 |  |  |  |  |  |  |  |  |
Number of options exercisable (in shares) |  |  | 25,657 |  |  |  |  |  |  |  |  |
Exercise price (in dollars per share) | $ / shares |  |  |  | 30.02 |  |  |  |  |  |  |  |
Estimated grant date fair value | $ |  | 439 |  |  |  |  |  |  |  |  |  |
Weighted average remaining life | 1 year 5 months 26 days |  |  |  |  |  |  |  |  |  |  |
Option Expiration Period Twenty Five |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items] |  |  |  |  |  |  |  |  |  |  |  |
Number of share options outstanding (in shares) |  |  | 13,158 |  |  |  |  |  |  |  |  |
Number of options exercisable (in shares) |  |  | 9,868 |  |  |  |  |  |  |  |  |
Exercise price (in dollars per share) | $ / shares |  |  |  | 27.17 |  |  |  |  |  |  |  |
Estimated grant date fair value | $ |  | 150 |  |  |  |  |  |  |  |  |  |
Weighted average remaining life | 1 year 7 months 17 days |  |  |  |  |  |  |  |  |  |  |
Option Expiration Period Twenty Six |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items] |  |  |  |  |  |  |  |  |  |  |  |
Number of share options outstanding (in shares) |  |  | 32,896 |  |  |  |  |  |  |  |  |
Number of options exercisable (in shares) |  |  | 32,896 |  |  |  |  |  |  |  |  |
Exercise price (in dollars per share) | $ / shares |  |  |  | 57.00 |  |  |  |  |  |  |  |
Estimated grant date fair value | $ |  | 1,352 |  |  |  |  |  |  |  |  |  |
Weighted average remaining life | 1 year 9 months |  |  |  |  |  |  |  |  |  |  |
Option Expiration Period Twenty Seven |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items] |  |  |  |  |  |  |  |  |  |  |  |
Number of share options outstanding (in shares) |  |  | 526 |  |  |  |  |  |  |  |  |
Number of options exercisable (in shares) |  |  | 526 |  |  |  |  |  |  |  |  |
Exercise price (in dollars per share) | $ / shares |  |  |  | 42.94 |  |  |  |  |  |  |  |
Estimated grant date fair value | $ |  | 16 |  |  |  |  |  |  |  |  |  |
Weighted average remaining life | 1 year 11 months 1 day |  |  |  |  |  |  |  |  |  |  |
Option Expiration Period Twenty Eight |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items] |  |  |  |  |  |  |  |  |  |  |  |
Number of share options outstanding (in shares) |  |  | 10,526 |  |  |  |  |  |  |  |  |
Number of options exercisable (in shares) |  |  | 10,526 |  |  |  |  |  |  |  |  |
Exercise price (in dollars per share) | $ / shares |  |  |  | 38.76 |  |  |  |  |  |  |  |
Estimated grant date fair value | $ |  | 295 |  |  |  |  |  |  |  |  |  |
Weighted average remaining life | 1 year 11 months 8 days |  |  |  |  |  |  |  |  |  |  |
Option Expiration Period Twenty Nine |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items] |  |  |  |  |  |  |  |  |  |  |  |
Number of share options outstanding (in shares) |  |  | 277,949 |  |  |  |  |  |  |  |  |
Number of options exercisable (in shares) |  |  | 277,949 |  |  |  |  |  |  |  |  |
Exercise price (in dollars per share) | $ / shares |  |  |  | 16.72 |  |  |  |  |  |  |  |
Estimated grant date fair value | $ |  | 3,710 |  |  |  |  |  |  |  |  | $ 4,080 |
Weighted average remaining life | 3 years 3 months |  |  |  |  |  |  |  |  |  |  |
Option Expiration Period Thirty |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items] |  |  |  |  |  |  |  |  |  |  |  |
Number of share options outstanding (in shares) |  |  | 2,632 |  |  |  |  |  |  |  |  |
Number of options exercisable (in shares) |  |  | 2,632 |  |  |  |  |  |  |  |  |
Exercise price (in dollars per share) | $ / shares |  |  |  | 30.02 |  |  |  |  |  |  |  |
Estimated grant date fair value | $ |  | 59 |  |  |  |  |  |  |  |  |  |
Weighted average remaining life | 3 years 5 months 26 days |  |  |  |  |  |  |  |  |  |  |
Option Expiration Period Thirty One |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items] |  |  |  |  |  |  |  |  |  |  |  |
Number of share options outstanding (in shares) |  |  | 526 |  |  |  |  |  |  |  |  |
Number of options exercisable (in shares) |  |  | 394 |  |  |  |  |  |  |  |  |
Exercise price (in dollars per share) | $ / shares |  |  |  | 21.28 |  |  |  |  |  |  |  |
Estimated grant date fair value | $ |  | 8 |  |  |  |  |  |  |  | $ 8 |  |
Weighted average remaining life | 3 years 11 months 19 days |  |  |  |  |  |  |  |  |  |  |
Option Expiration Period Thirty Two |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items] |  |  |  |  |  |  |  |  |  |  |  |
Number of share options outstanding (in shares) |  |  | 284,873 |  |  |  |  |  |  |  |  |
Number of options exercisable (in shares) |  |  | 177,994 |  |  |  |  |  |  |  |  |
Exercise price (in dollars per share) | $ / shares |  |  |  | 21.28 |  |  |  |  |  |  |  |
Estimated grant date fair value | $ |  | 3,742 |  |  |  |  |  | $ 4,619 |  |  |  |
Weighted average remaining life | 4 years 3 days |  |  |  |  |  |  |  |  |  |  |
Option Expiration Period Thirty Three |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items] |  |  |  |  |  |  |  |  |  |  |  |
Number of share options outstanding (in shares) |  |  | 7,895 |  |  |  |  |  |  |  |  |
Number of options exercisable (in shares) |  |  | 7,895 |  |  |  |  |  |  |  |  |
Exercise price (in dollars per share) | $ / shares |  |  |  | 34.20 |  |  |  |  |  |  |  |
Estimated grant date fair value | $ |  | 179 |  |  |  |  |  |  |  |  |  |
Weighted average remaining life | 7 years 3 months |  |  |  |  |  |  |  |  |  |  |
Option Expiration Period Thirty Four |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items] |  |  |  |  |  |  |  |  |  |  |  |
Number of share options outstanding (in shares) |  |  | 3,049,784 |  |  |  |  |  |  |  |  |
Number of options exercisable (in shares) |  |  | 2,877,860 |  |  |  |  |  |  |  |  |
Exercise price (in dollars per share) | $ / shares |  |  |  | 13.11 |  |  |  |  |  |  |  |
Estimated grant date fair value | $ |  | 34,032 |  |  |  |  | $ 34,822 |  |  |  |  |
Weighted average remaining life | 9 years 4 months 13 days |  |  |  |  |  |  |  |  |  |  |
Option Expiration Period Thirty Five |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items] |  |  |  |  |  |  |  |  |  |  |  |
Number of share options outstanding (in shares) |  |  | 80,100 |  |  |  |  |  |  |  |  |
Number of options exercisable (in shares) |  |  | 23,867 |  |  |  |  |  |  |  |  |
Exercise price (in dollars per share) | $ / shares |  |  |  | 14.37 |  |  |  |  |  |  |  |
Estimated grant date fair value | $ |  | 507 |  |  |  | $ 982 |  |  |  |  |  |
Weighted average remaining life | 9 years 7 months 28 days |  |  |  |  |  |  |  |  |  |  |
Option Expiration Period Thirty Six |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items] |  |  |  |  |  |  |  |  |  |  |  |
Number of share options outstanding (in shares) |  |  | 35,000 |  |  |  |  |  |  |  |  |
Number of options exercisable (in shares) |  |  | 8,750 |  |  |  |  |  |  |  |  |
Exercise price (in dollars per share) | $ / shares |  |  |  | $ 10.45 |  |  |  |  |  |  |  |
Estimated grant date fair value | $ |  | $ 109 |  |  | $ 307 |  |  |  |  |  |  |
Weighted average remaining life | 9 years 11 months 4 days |  |  |  |  |  |  |  |  |  |  |

X
- Definition Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table. + References No definition available. + Details
Name: | ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The exercise price of outstanding share options. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2024-01-01 -Paragraph 45 -Subparagraph d -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_45_d&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_ExercisePriceOfOutstandingShareOptions2019
Namespace Prefix: | ifrs-full_
Data Type: | dtr-2022:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition The number of share options outstanding in a share-based payment arrangement. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2024-01-01 -Paragraph 45 -Subparagraph d -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_45_d&doctype=Standard -URIDate 2024-03-27 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2024-01-01 -Paragraph 45 -Subparagraph b -Clause i -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_45_b_i&doctype=Standard -URIDate 2024-03-27 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2024-01-01 -Paragraph 45 -Subparagraph b -Clause vi -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_45_b_vi&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_NumberOfOutstandingShareOptions
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:decimalItemType
Balance Type: | na
Period Type: | instant

X
- Definition The number of share options exercisable in a share-based payment arrangement. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2024-01-01 -Paragraph 45 -Subparagraph b -Clause vii -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_45_b_vii&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:decimalItemType
Balance Type: | na
Period Type: | instant

X
- Definition The weighted average fair value of share options granted during the period at the measurement date. [Refer: Weighted average [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2024-01-01 -Paragraph 47 -Subparagraph a -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_47_a&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The weighted average remaining contractual life of outstanding share options. [Refer: Weighted average [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2024-01-01 -Paragraph 45 -Subparagraph d -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2024-en-r&anchor=para_45_d&doctype=Standard -URIDate 2024-03-27 + Details
Name: | ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | cybn_OptionExpirationPeriodAxis=cybn_OptionExpirationPeriodOneMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | cybn_OptionExpirationPeriodAxis=cybn_OptionExpirationPeriodTwoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | cybn_OptionExpirationPeriodAxis=cybn_OptionExpirationPeriodThreeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | cybn_OptionExpirationPeriodAxis=cybn_OptionExpirationPeriodFourMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | cybn_OptionExpirationPeriodAxis=cybn_OptionExpirationPeriodFiveMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | cybn_OptionExpirationPeriodAxis=cybn_OptionExpirationPeriodSixMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | cybn_OptionExpirationPeriodAxis=cybn_OptionExpirationPeriodSevenMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | cybn_OptionExpirationPeriodAxis=cybn_OptionExpirationPeriodEightMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | cybn_OptionExpirationPeriodAxis=cybn_OptionExpirationPeriodNineMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | cybn_OptionExpirationPeriodAxis=cybn_OptionExpirationPeriodTenMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | cybn_OptionExpirationPeriodAxis=cybn_OptionExpirationPeriodElevenMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | cybn_OptionExpirationPeriodAxis=cybn_OptionExpirationPeriodTwelveMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | cybn_OptionExpirationPeriodAxis=cybn_OptionExpirationPeriodThirteenMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | cybn_OptionExpirationPeriodAxis=cybn_OptionExpirationPeriodFourteenMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | cybn_OptionExpirationPeriodAxis=cybn_OptionExpirationPeriodFifteenMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | cybn_OptionExpirationPeriodAxis=cybn_OptionExpirationPeriodSixteenMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | cybn_OptionExpirationPeriodAxis=cybn_OptionExpirationPeriodSeventeenMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | cybn_OptionExpirationPeriodAxis=cybn_OptionExpirationPeriodEighteenMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | cybn_OptionExpirationPeriodAxis=cybn_OptionExpirationPeriodNineteenMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | cybn_OptionExpirationPeriodAxis=cybn_OptionExpirationPeriodTwentyMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | cybn_OptionExpirationPeriodAxis=cybn_OptionExpirationPeriodTwentyOneMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | cybn_OptionExpirationPeriodAxis=cybn_OptionExpirationPeriodTwentyTwoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | cybn_OptionExpirationPeriodAxis=cybn_OptionExpirationPeriodTwentyThreeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | cybn_OptionExpirationPeriodAxis=cybn_OptionExpirationPeriodTwentyFourMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | cybn_OptionExpirationPeriodAxis=cybn_OptionExpirationPeriodTwentyFiveMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | cybn_OptionExpirationPeriodAxis=cybn_OptionExpirationPeriodTwentySixMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | cybn_OptionExpirationPeriodAxis=cybn_OptionExpirationPeriodTwentySevenMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | cybn_OptionExpirationPeriodAxis=cybn_OptionExpirationPeriodTwentyEightMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | cybn_OptionExpirationPeriodAxis=cybn_OptionExpirationPeriodTwentyNineMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | cybn_OptionExpirationPeriodAxis=cybn_OptionExpirationPeriodThirtyMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | cybn_OptionExpirationPeriodAxis=cybn_OptionExpirationPeriodThirtyOneMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | cybn_OptionExpirationPeriodAxis=cybn_OptionExpirationPeriodThirtyTwoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | cybn_OptionExpirationPeriodAxis=cybn_OptionExpirationPeriodThirtyThreeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | cybn_OptionExpirationPeriodAxis=cybn_OptionExpirationPeriodThirtyFourMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | cybn_OptionExpirationPeriodAxis=cybn_OptionExpirationPeriodThirtyFiveMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | cybn_OptionExpirationPeriodAxis=cybn_OptionExpirationPeriodThirtySixMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |